Targeted alpha therapy using [Bi-213]Substance P overcomes chemo- and radioresistance in glioblastoma and glioblastoma stem cells

被引：0
|
作者：
Friesen, C. [1 ]
Hormann, I. [1 ]
Roscher, M. [1 ]
Morgenstern, A. [2 ]
Bruchertseifer, F. [2 ]
Maecke, H. [3 ]
Fulda, S. [4 ]
Apostolidis, C. [2 ]
Debatin, K. -M. [4 ]
Miltner, E. [1 ]
机构：
[1] Univ Ulm, Inst Rechts Med, Ulm, Germany
[2] Europa Kommiss, Inst Transurane, Karlsruhe, Germany
[3] Univ Freiburg, Freiburg, Germany
[4] Univ Ulm, Klin Kinder & Jugendmed, Ulm, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：179 / 179
页数：1
相关论文
共 50 条
  • [21] In vitro evaluation of 225Ac-DOTA-substance P for targeted alpha therapy of glioblastoma multiforme
    Majkowska-Pilip, Agnieszka
    Rius, Maria
    Bruchertseifer, Frank
    Apostolidis, Christos
    Weis, Mirjam
    Bonelli, Milton
    Laurenza, Marta
    Krolicki, Leszek
    Morgenstern, Alfred
    CHEMICAL BIOLOGY & DRUG DESIGN, 2018, 92 (01) : 1344 - 1356
  • [22] Role of glioma stem cells in promoting tumor chemo- and radioresistance: A systematic review of potential targeted treatments
    Agosti, Edoardo
    Zeppieri, Marco
    Ghidoni, Mattia
    Ius, Tamara
    Tel, Alessandro
    Fontanella, Marco Maria
    Panciani, Pier Paolo
    WORLD JOURNAL OF STEM CELLS, 2024, 16 (05): : 604 - 614
  • [23] Alphaknife for glioma tumors: two years experiences with targeted alpha therapy of 213Bi-substance P
    Krolicki, L.
    Morgenstern, A.
    Kunikowska, J.
    Koziara, H.
    Krolicki, B.
    Jakucinski, M.
    Apostolidis, C.
    Bruchertseifer, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S291 - S292
  • [24] Targeted radiotherapy using alpha-particles breaks chemo- and radioresistance by reversing deficient activation of apoptosis pathways in radio-, chemo- and apoptosis-resistant leukemia cells
    Friesen, C.
    Glatting, G.
    Reske, S.
    Debatin, K. -M.
    Miltner, E.
    ONKOLOGIE, 2008, 31 : 173 - 173
  • [25] An improved method for the production of Ac-225/Bi-213 from Th-229 for targeted alpha therapy
    Zielinska, B.
    Apostolidis, C.
    Bruchertseifer, F.
    Morgenstern, A.
    SOLVENT EXTRACTION AND ION EXCHANGE, 2007, 25 (03) : 339 - 349
  • [26] Overcoming chemo- and radioresistance and deficient activation of apoptosis pathways in leukemia cells using Auger-electron-DNA-targeted therapy
    Friesen, C.
    Glatting, G.
    Zlatopolskiy, B.
    Debatin, K. M.
    Reske, S. N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S209 - S209
  • [27] Interferon-β Induces Loss of Spherogenicity and Overcomes Therapy Resistance of Glioblastoma Stem Cells
    Happold, Caroline
    Roth, Patrick
    Silginer, Manuela
    Florea, Ana-Maria
    Lamszus, Katrin
    Frei, Karl
    Deenen, Rene
    Reifenberger, Guido
    Weller, Michael
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (04) : 948 - 961
  • [28] Synthesis of 213Bi-DOTA-Substance P for targeted alpha-radionuclide therapy in patients with malignant glioma
    Bruchertseifer, F.
    Cordier, D.
    Forrer, F.
    Kneifel, S.
    Apostolidis, C.
    Morgenstern, A.
    Merlo, A.
    Maecke, H. R.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (04) : 513 - 513
  • [29] Synthesis of 213Bi-DOTA-Substance P for Targeted Alpha-Radionuclide Therapy in Patients with Malignant Glioma
    Bruchertseifer, F.
    Cordier, D.
    Forrer, F.
    Kneifel, S.
    Apostolidis, C.
    Morgenstern, A.
    Merlo, A.
    Maecke, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S149 - S149
  • [30] Nanoparticle-engineered probing of neural stem cells targeted therapy for glioblastoma
    Cheng, Shih-Hsun
    Balyasnikova, Irina
    Tsai, Hsiu-Ming
    Lai, Xiaochun
    Meng, Ling-Jian
    Aboody, Karen
    Lesniak, Maciej
    Lo, Leu-Wei
    Chen, Chin-Tu
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
12345